Description: Leidos Biomedical Research, Inc. seeks a qualified vendor to perform FDA-mandated safety analyses of influenza vaccines under solicitation S26-141. The work includes repeat-dose toxicology studies in New Zealand White Rabbits conducted according to U.S. Good Laboratory Practices standards. Amendment 01 extended the proposal deadline to October 21, 2026, at noon Eastern Time, and the full solicitation package is available by contacting Maureen Wilson.
Federal · MD, US
Original attachments and procurement documents tied to this bid.
Federal RFP files are for Starbridge customers only.
You can request RFP files from all other buyer types for free on this site.
Adjacent opportunities open for bidding right now.
FederalDC
Posted
Sep 11, 2026
Nov 20, 2026
Provide BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response .
Posted
Aug 17, 2026
Oct 30, 2026
BARDA seeks contractors to continue the Vaccine Medical Countermeasures program for pandemic influenza preparedness and response. The work includes supplying services, personnel, facilities, vaccines, antigens, and adjuvants; producing influenza or other pandemic-potential vaccines; and supporting FDA regulatory and manufacturing-readiness activities. Offerors must produce influenza vaccines and demonstrate qualifying manufacturing experience, and the notice directs respondents to the solicitation attachments for submission instructions.
Iowa Department of Natural Resources
State AgencyIA
Posted
Sep 30, 2026
Oct 22, 2026
This project is Phase II, and will be the final construction phase of the interior build-out of an existing wood framed construction building. This phase will include finishing of wall, ceiling, and flooring surfaces in building restroom, office area and mechanical spaces. New plumbing fixtures and accessories will be installed in restroom. New lighting fixtures, receptacles, and switches will be installed. Mechanical, electrical, and plumbing work will be included in this phase of work.
Posted
Aug 7, 2026
Oct 19, 2026
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals for a multifunctional, target-agnostic platform for precise, programmable editing of endogenous proteins. The Protein ENGineering (PENG) program seeks to transition proteome engineering from isolated, bespoke tools into a universal, software-defined discipline. It will establish an integrated platform with modular targeting, generalizable effector chemistries, and multiplexed control systems.
Decision makers connected to this RFP from NIH NCI.
